Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. LVS
8. CSX
9. LRCX
10. MRK

Go back to Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offer

Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"

November 4, 2025 9:09 AM EST

Novo Nordisk Amended Proposal Values Metsera at up to $ 86.20 per Share, a Total of Approximately $ 10.0 Billion

Superior to Revised Pfizer Proposal that Valued Metsera at up to $ 70.00 per Share, a Total of Approximately $ 8.1 Billion

Pursuant to Pfizer Merger Agreement, Metsera and Pfizer May Negotiate Potential Adjustments for Two Business Days

Pfizer Merger Agreement Remains in Effect; No Action Required by Metsera Shareholders

... More